We look forward to being a part of the New England Venture Summit this week.
At GenEndeavor, our mission is clear: to prevent genetic and infectious diseases through early detection of pathological biomarkers. We're excited to share more details about our platform designed for the early detection of ovarian cancer, especially for high-risk asymptomatic women. If you're attending the summit, we’d welcome a conversation about @GenEndeavor’s investment opportunities. Please reach out if you’re interested. amanda@genedeavor.com.
https://youngstartup.com/events/nevs23